MRK - Merck & Co., Inc.


119.83
-1.580   -1.319%

Share volume: 9,276,447
Last Updated: 03-03-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.15%

PREVIOUS CLOSE
CHG
CHG%

$121.41
-1.58
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Report Date 05-03-2024 08-05-2024 11-06-2024 02-25-2025 05-02-2025 08-05-2025 11-05-2025 02-24-2026
Total revenue 15.775 B 16.112 B 16.657 B 15.624 B 15.529 B 15.806 B 17.276 B 16.400 B
Cost of revenue 3.540 B 3.745 B 4.080 B 3.828 B 3.419 B 3.557 B 3.855 B 5.551 B
Gross profit 12.235 B 12.367 B 12.577 B 11.796 B 12.110 B 12.249 B 13.421 B 10.849 B
    1.08% 1.70% -6.21% 2.66% 1.15% 9.57% -19.16%  
Operating expenses 6.475 B 6.239 B 8.593 B 7.447 B 6.173 B 6.697 B 6.867 B 6.785 B
Selling general and admin 2.483 B 2.739 B 2.731 B 2.863 B 2.552 B 2.649 B 2.633 B 2.899 B
Research and development 3.992 B 3.500 B 5.862 B 4.584 B 3.621 B 4.048 B 4.234 B 3.886 B
Total expenses 6.598 B 6.319 B 8.649 B 7.497 B 6.242 B 7.257 B 6.914 B 6.998 B
    -4.23% 36.87% -13.32% -16.74% 16.26% -4.73% 1.21%  
Operating income 5.637 B 6.048 B 3.928 B 4.299 B 5.868 B 4.992 B 6.507 B 3.851 B
Ebit 5.670 B 6.006 B 4.090 B 4.170 B 5.903 B 4.999 B 6.745 B 3.420 B
Pretax income 5.670 B 6.006 B 4.090 B 4.170 B 5.903 B 4.999 B 6.745 B 3.420 B
    5.93% -31.90% 1.96% 41.56% -15.31% 34.93% -49.30%  
Income tax 903.000 M 545.000 M 929.000 M 426.000 M 818.000 M 571.000 M 958.000 M 457.000 M
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                   
Net income 4.767 B 5.461 B 3.161 B 3.744 B 5.085 B 4.428 B 5.787 B 2.963 B
    14.56% -42.12% 18.44% 35.82% -12.92% 30.69% -48.80%